SCHEMBL24832295

SCHEMBL24832295

Clc1nc2ccc(Br)cc2n2ccnc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 1/20 0.45
NPM1 P06748 3/20 0.41
ALK Q9UM73 3/20 0.41
PDE2A O00408 1/20 0.37
PDE10A Q9Y233 1/20 0.37
CUL4A Q13619 1/20 0.36
LCK P06239 1/20 0.36
GRIN2D O15399 1/20 0.35
GRIN3B O60391 1/20 0.35
GRIA1 P42261 1/20 0.35
GRIA2 P42262 1/20 0.35
GRIA3 P42263 1/20 0.35
GRIA4 P48058 1/20 0.35
GRIN1 Q05586 1/20 0.35
GRIN2A Q12879 1/20 0.35
GRIN2B Q13224 1/20 0.35
GRIN2C Q14957 1/20 0.35
GRIN3A Q8TCU5 1/20 0.35
HRH4 Q9H3N8 1/20 0.35
MAPK8 P45983 4/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3496046 0.88 HTR3E (0.40) IKBKBPDE2ALCKGRIN2DGRIN3B
SCHEMBL8102963 0.84 CUL4A (0.51) IKBKBPDE2APDE10ACUL4AHRH4
SCHEMBL13077027 0.82 IKBKB (0.66) IKBKBHRH4MAPK8KDM4EALDH1A1
SCHEMBL25824093 0.82 IKBKB (0.45) IKBKBCUL4AGRIN2DGRIN3BGRIA1
SCHEMBL121472 0.82 HTR3E (0.45) IKBKBPDE2APDE10ACUL4ALCK
SCHEMBL30973203 0.82 IKBKB (0.45) IKBKBCUL4AGRIN2DGRIN3BGRIA1
SCHEMBL17895298 0.78 IKBKB (0.42) IKBKBPDE2APDE10ACDC7CDK2
SCHEMBL30578099 0.78 MAPK8 (0.54) IKBKBMAPK8KDM4EALDH1A1GLA
SCHEMBL120846 0.78 MAPK8 (0.54) IKBKBMAPK8KDM4EALDH1A1GLA
SCHEMBL8118650 0.78 GRIN2D (0.49) IKBKBGRIN2DGRIN3BGRIA1GRIA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219960-A1 1H-PYRAZOLE DERIVATIVE AND APPLICATION THEREOF AS DUAL TARGET INHIBITOR OF SYK AND VEGFR2 OCUMENSION THERAPEUTICS (SUZHOU) CO., LTD. (CN) 2023-07-13 US disclosed
US-20230219960-A1 1H-PYRAZOLE DERIVATIVE AND APPLICATION THEREOF AS DUAL TARGET INHIBITOR OF SYK AND VEGFR2 OCUMENSION THERAPEUTICS (SUZHOU) CO., LTD. (CN) 2023-07-13 US disclosed
EP-4112621-A1 1H-PYRAZOLE DERIVATIVE AND APPLICATION THEREOF AS DUAL TARGET INHIBITOR OF SYK AND VEGFR2 Ocumension Therapeutics (Suzhou) Co., Ltd. (CN) 2023-01-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219960-A1 1H-PYRAZOLE DERIVATIVE AND APPLICATION THEREOF AS DUAL TARGET INHIBITOR OF SYK AND VEGFR2 SYK, KDR, FLT1 IKBKB 275/4885NPM1 3719/4885ALK 170/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.